A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Clinical trial NCT07540572 · RECRUITING

Trial details

NCT number: NCT07540572
Sponsor: IDEAYA Biosciences
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

ER+, HER 2- Breast Cancer Non-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)Microsatellite Stable (MSS) Colorectal Carcinoma

Start date: 2026-03-17
Primary completion: 2030-03-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.